These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33106609)

  • 21. Durability of Diabetic Retinopathy Improvement with As-Needed Ranibizumab: Open-Label Extension of RIDE and RISE Studies.
    Sun JK; Wang PW; Taylor S; Haskova Z
    Ophthalmology; 2019 May; 126(5):712-720. PubMed ID: 30419298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of calcium dobesilate in treating Chinese patients with mild-to-moderate non-proliferative diabetic retinopathy (CALM-DR): protocol for a single-blind, multicentre, 24-armed cluster-randomised, controlled trial.
    Hu H; Liu J; Wang D; Qiu S; Yuan Y; Wang F; Wen L; Song Q; Sun ZL
    BMJ Open; 2021 May; 11(5):e045256. PubMed ID: 34049911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Statin Therapy With Prevention of Vision-Threatening Diabetic Retinopathy.
    Kang EY; Chen TH; Garg SJ; Sun CC; Kang JH; Wu WC; Hung MJ; Lai CC; Cherng WJ; Hwang YS
    JAMA Ophthalmol; 2019 Apr; 137(4):363-371. PubMed ID: 30629109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of diabetic retinopathy using two ultra-wide-field fundus imaging systems, the Clarus® and Optos™ systems.
    Hirano T; Imai A; Kasamatsu H; Kakihara S; Toriyama Y; Murata T
    BMC Ophthalmol; 2018 Dec; 18(1):332. PubMed ID: 30572870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in patients with severe nonproliferative or non-high-risk proliferative diabetic retinopathy: a randomized clinical trial.
    Scott IU; Jackson GR; Quillen DA; Larsen M; Klein R; Liao J; Holfort S; Munch IC; Gardner TW
    JAMA Ophthalmol; 2014 May; 132(5):535-43. PubMed ID: 24604308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects of ranibizumab on diabetic retinopathy severity and progression.
    Ip MS; Domalpally A; Hopkins JJ; Wong P; Ehrlich JS
    Arch Ophthalmol; 2012 Sep; 130(9):1145-52. PubMed ID: 22965590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in Diabetic Retinopathy, Visual Acuity, and Treatment Outcomes for Patients Living With Diabetes in a Fundus Photograph-Based Diabetic Retinopathy Screening Program in Bangladesh.
    Muqit MMK; Kourgialis N; Jackson-deGraffenried M; Talukder Z; Khetran ER; Rahman A; Chan WO; Chowdury FA; Nag D; Ahmad J; Friedman DS
    JAMA Netw Open; 2019 Nov; 2(11):e1916285. PubMed ID: 31774523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between Diabetic Retinopathy Severity and Oxygen Metabolism in Patients with Diabetic Macular Edema during Treatment with Intravitreal Aflibercept.
    Blindbæk SL; Peto T; Grauslund J
    Ophthalmic Res; 2020; 63(2):106-113. PubMed ID: 31715608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ranibizumab Induces Regression of Diabetic Retinopathy in Most Patients at High Risk of Progression to Proliferative Diabetic Retinopathy.
    Wykoff CC; Eichenbaum DA; Roth DB; Hill L; Fung AE; Haskova Z
    Ophthalmol Retina; 2018 Oct; 2(10):997-1009. PubMed ID: 31047503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small Dense Low-Density Lipoprotein Cholesterol is a Potential Marker for Predicting Laser Treatment for Retinopathy in Diabetic Patients.
    Nakayama A; Morita H; Sato T; Kawahara T; Takeda N; Kato S; Itoh H; Komuro I
    J Atheroscler Thromb; 2022 May; 29(5):678-691. PubMed ID: 33994406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemorrhage and/or Microaneurysm Severity and Count in Ultrawide Field Images and Early Treatment Diabetic Retinopathy Study Photography.
    Silva PS; El-Rami H; Barham R; Gupta A; Fleming A; van Hemert J; Cavallerano JD; Sun JK; Aiello LP
    Ophthalmology; 2017 Jul; 124(7):970-976. PubMed ID: 28336057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study.
    Chew EY; Davis MD; Danis RP; Lovato JF; Perdue LH; Greven C; Genuth S; Goff DC; Leiter LA; Ismail-Beigi F; Ambrosius WT;
    Ophthalmology; 2014 Dec; 121(12):2443-51. PubMed ID: 25172198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High remnant cholesterol level is relevant to diabetic retinopathy in type 2 diabetes mellitus.
    Shan Y; Wang Q; Zhang Y; Tong X; Pu S; Xu Y; Gao X
    Lipids Health Dis; 2022 Jan; 21(1):12. PubMed ID: 35057797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy.
    Ip MS; Domalpally A; Sun JK; Ehrlich JS
    Ophthalmology; 2015 Feb; 122(2):367-74. PubMed ID: 25439595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.
    Matthews DR; Stratton IM; Aldington SJ; Holman RR; Kohner EM;
    Arch Ophthalmol; 2004 Nov; 122(11):1631-40. PubMed ID: 15534123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visual fields correlate better than visual acuity to severity of diabetic retinopathy.
    Bengtsson B; Heijl A; Agardh E
    Diabetologia; 2005 Dec; 48(12):2494-500. PubMed ID: 16261313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microalbuminuria and low hemoglobin as risk factors for the occurrence and increasing severity of diabetic retinopathy.
    Ajoy Mohan VK; Nithyanandam S; Idiculla J
    Indian J Ophthalmol; 2011; 59(3):207-10. PubMed ID: 21586841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipids and Diabetic Retinopathy.
    Modjtahedi BS; Bose N; Papakostas TD; Morse L; Vavvas DG; Kishan AU
    Semin Ophthalmol; 2016; 31(1-2):10-8. PubMed ID: 26959124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progression of diabetic retinopathy severity after treatment with dexamethasone implant: a 24-month cohort study the 'DR-Pro-DEX Study'.
    Iglicki M; Zur D; Busch C; Okada M; Loewenstein A
    Acta Diabetol; 2018 Jun; 55(6):541-547. PubMed ID: 29497837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of digital and film grading of diabetic retinopathy severity in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Hubbard LD; Sun W; Cleary PA; Danis RP; Hainsworth DP; Peng Q; Susman RA; Aiello LP; Davis MD;
    Arch Ophthalmol; 2011 Jun; 129(6):718-26. PubMed ID: 21670338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.